Capucine L Grandjean

5PUBLICATIONS
20CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 10, 2026
Lymph node microenvironment remodeling unlocks local antibody-mediated B cell depletion.

|Aug 15, 2025
Reprogramming RIPK3-induced cell death in malignant B cells promotes immune-mediated tumor control.

Ruby Alonso, Zacarias Garcia, Béatrice Corre

|Feb 28, 2024
Anti-PD-1 therapy triggers Tfh cell-dependent IL-4 release to boost CD8 T cell responses in tumor-draining lymph nodes.

Mathilde Ruggiu, Marion V Guérin, Béatrice Corre

|Mar 27, 2021
A cross-talk between CAR T cell subsets and the tumor microenvironment is essential for sustained cytotoxic activity.

Morgane Boulch, Marine Cazaux, Yann Loe-Mie

|Feb 20, 2021
Imaging the mechanisms of anti-CD20 therapy in vivo uncovers spatiotemporal bottlenecks in antibody-dependent phagocytosis.

Capucine L Grandjean, Zacarias Garcia, Fabrice Lemaître

Pageof 1

Frequent Collaborators

5 joint publications

Zacarias Garcia

5 joint publications

Philippe Bousso

3 joint publications

Fabrice Lemaître

2 joint publications

Marion V Guérin